Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error. The previously visible study record for NCT01441947 is no longer accessible on this ClinicalTrials.gov page.
    Difference
    19%
    Check dated 2026-09-23T00:58:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page displays Revision: v3.7.0 instead of v3.6.6, indicating a minor update to the page template or content management system. This change does not alter the study details or results on the page.
    Difference
    0.1%
    Check dated 2026-09-16T00:10:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This appears to be a minor metadata update and does not modify the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-09-01T19:24:49.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page shows a new revision indicator: v3.6.5, replacing v3.6.4. This reflects an update to the page build rather than any changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-11T08:21:16.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.4, signaling a newer revision of the page. This appears to be a maintenance update rather than a substantive change to study information.
    Difference
    0.1%
    Check dated 2026-07-28T04:59:04.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new page revision label, v3.6.3, was added and the previous label v3.6.2 was removed. This indicates an update to the page's versioning, without changes to the study text or data presented.
    Difference
    0.1%
    Check dated 2026-07-06T16:39:02.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.